High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures?
Carella, A M
High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures? [electronic resource] - Haematologica - 348-51 p. digital
Publication Type: Journal Article; Review
0390-6078
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Blood Component Transfusion
Blood Transfusion, Autologous
Bone Marrow Transplantation
Combined Modality Therapy
Cytarabine--administration & dosage
Etoposide--administration & dosage
Female
Hematopoietic Stem Cell Transplantation
Humans
Idarubicin--administration & dosage
Male
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Prognosis
Remission Induction
Translocation, Genetic
Whole-Body Irradiation
High-risk acute lymphoblastic leukemia (ALL): is there an alternative approach for increasing the number of cures? [electronic resource] - Haematologica - 348-51 p. digital
Publication Type: Journal Article; Review
0390-6078
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Blood Component Transfusion
Blood Transfusion, Autologous
Bone Marrow Transplantation
Combined Modality Therapy
Cytarabine--administration & dosage
Etoposide--administration & dosage
Female
Hematopoietic Stem Cell Transplantation
Humans
Idarubicin--administration & dosage
Male
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Prognosis
Remission Induction
Translocation, Genetic
Whole-Body Irradiation